BioSpace News Archive

Lilly Declares Fourth-Quarter 2018 Dividend

- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2018 of $0.5625 per share on outstanding common stock

October 15, 2018
·
1 min read
Policy

The Government of Canada takes next steps on post-traumatic stress injuries action plan

Public safety officers, military personnel and Veterans play a critical role in keeping our communities safe – putting their lives and mental and physical well-being on the line to protect us.

October 15, 2018
·
5 min read
Business

BayCare Health Plans Launches Insurance Products

BayCare Health Plans begins enrollment in its first health insurance products, two Medicare Advantage (HMO) plans called BayCarePlus.

October 15, 2018
·
2 min read
BioMidwest

Medline Awards $150,000 in Breast Cancer Community Grants for Innovative Programs

Medline has awarded $150,000 in its inaugural Medline Breast Cancer Awareness grants to six organizations fighting to eradicate breast cancer and providing counseling.

October 15, 2018
·
2 min read
Business

Transaction Data Systems Partners with Community Pharmacies to Fight the Opioid Epidemic with Release of NarcFacts

Transaction Data Systems, Inc., the leader in pharmacy management software including Rx30 and Computer-Rx, is helping community pharmacies fight controlled substance abuse with integrated tools to streamline PDMP review.

October 15, 2018
·
2 min read
QIAGEN’s Next-Generation QIAstat-Dx System Delivers Fast, Cost-Effective Diagnosis of Gastrointestinal Syndromes

New gastrointestinal panel includes comprehensive viral coverage and provides Sample to Insight workflows to clinics in Europe and Australia

October 15, 2018
·
2 min read
Deals

MERGER CREATES NEW GLOBAL LEADER IN BIOSPECIMEN SOLUTIONS: FOUR COMPANIES UNITE TO FORM DISCOVERY LIFE SCIENCES

Conversant Bio, Folio Bio, Discovery Life Sciences and Phylogeny announced today that they have merged under the name Discovery Life Sciences™ (Discovery) to create a global market leader in biospecimen analysis and procurement for the pharmaceutical, biotechnology and diagnostics industries.

October 15, 2018
·
2 min read
Business

Enzo Biochem Reports Fourth Quarter and Fiscal 2018 Results

Molecular Assay Approvals from New York State Department of Health and Planned Acquisition of New Facility Highlight Progress Advancing Growth Strategy

October 15, 2018
·
17 min read
Business

Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results on Monday, October 29, 2018

Veracyte, Inc. (Nasdaq: VCYT) will release its third quarter 2018 financial results after the close of market on Monday, October 29, 2018

October 15, 2018
·
1 min read
BioCapital

Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies

The FDA continues to advance new policies, modernize our programs and advance opportunities for developing more targeted therapies.

October 15, 2018
·
9 min read